Tuesday, July 28, 2009

Should Hospitals Have to Offer Long Term Care to Indigent Non-documented Immigrants?



Should Hospitals Have to Offer Long Term Care to Indigent Non-documented Immigrants

In a benchmark case dealing with the obligations of hospitals toward uninsured illegal immigrants, a Florida jury found that Martin Memorial Medical Center did not act unreasonably when it chartered a plane and repatriated a severely brain-injured Guatemalan patient against the will of his guardian.

Luis Jimenez, now 37, immigrated to the United States from Guatemala in order to support his family. But in 2000, a drunk driver crashed into a van he was riding in and left him a paraplegic. Martin Memorial Medical Center treated Jimenez for three years. For more than a year he lingered in a vegetative state. Now he has the mental capacity of small child. Over three years, Marin Memorial spent 1.5 million in Jimenez’s care.

In July 2003, Martin Memorial Medical Center chartered a private plane and sent Jimenez back to Guatemala without telling his relatives in the U.S. or Guatemala. Martin Memorial contends Jimenez wanted to go home and a state judge approved of sending Jimenez to Guatemala.

Montejo Gaspar, Jimenez’s cousin and legal guardian has sued the hospital for repatriating Jimenez. Lawsuit seeks nearly $1 million to cover the estimated lifetime costs of his care in Guatemala, as well as damages for the hospital’s alleged “false imprisonment” of his cousin.

The underlying question was what should a hospital do with a patient who requires long-term care, is unable to pay and doesn’t qualify for federal or state aid because of his immigration status. This appears to be the first time a lawsuit has been filed in such a case.

Just before jury deliberations, Senior Judge James Midelis told jurors that the only decision to be made was whether the hospital’s action were “unreasonable and unwarranted” under the circumstances. It has already been determined that Jimenez was “unlawfully detained and deprived of liberty” by the hospital and that the hospital had acted against the will of his legal guardian.

The all- White jury declined to comment on their verdict that the hospital did not act unreasonably in repatriating Jimenez to Guatemala.

http://www.nytimes.com/2009/07/28/us/28deport.html

Labels: , , , , ,

posted by Jessica at 7:19 AM

Monday, June 29, 2009

Accutane Pulled Off the Market after Jury Verdict

Roche Holding AG, one of biggest makers of cancer drugs, pulled its Accutane acne medicine from the U.S. market after juries awarded at least $33 million in damages to users who blamed the drug for bowel disease. Roche notified the FDA today that it would be withdrawing Accutane after a reevaluation of the product showed it faced serious challenges from generic competitors, company officials stated.

About 13 million people have used Accutane since it went on the market in 1982. The medication was Roche’s second-biggest selling drug before the patent expired in 2002 and rivals started selling generic versions. Roche’s prescription market share of the drug is now below 5 percent, the company said.

The company faces as many as 5,000 personal injury claims over Accutane, said Michael Hook, a Pensacola, Florida based attorney, who won a $10.5 million verdict against the drug maker over the medicine in April 2008. “We’ve been winning the cases with the drug still on the market, but this move certainly isn’t going to hurt us going forward”, Hook said in an interview today.

Use of Accutane has been linked to birth defects and depression. Users allege that the drug maker failed to properly warn that the medicine could cause inflammatory bowel disease.

For more information see: http://www.bloomberg.com/apps/news?pid=20670001&sid=aRyzfbTsj3h8

Labels: , , , ,

posted by Chavon Williams at 11:07 AM

Archives

Drug Injury and Recall Blog

Dangerous and Defective Pharmaceutical Products

1.800.873.5297 Email Us

Welcome to the dangerous prescription drugs website of Schlichter, Bogard & Denton,
please upgrade your Flash Plugin and enable JavaScript to see our pharmaceutical injury video.